ID

34741

Beschrijving

Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02324842

Link

https://clinicaltrials.gov/show/NCT02324842

Trefwoorden

Versies (1)
  1. 25-01-19 25-01-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

25 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 2 Diabetes Mellitus NCT02324842

Engels

Eligibility Type 2 Diabetes Mellitus NCT02324842

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female subjects between the ages of 18-70
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
subjects with type 2 diabetes mellitus (t2dm)
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
drug naïve or on stable dose (more than 3 months) of metformin
Beschrijving

Pharmaceutical Preparations Absent | Metformin Dose Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0025598
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
have an hba1c levels ≥7.0% and <10.0%
Beschrijving

Hemoglobin A1c measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0474680
stable weight (± 3 lbs) over the preceding 3 months
Beschrijving

Stable body weight Duration

Datatype

boolean

Alias
UMLS CUI [1,1]
C0517386
UMLS CUI [1,2]
C0449238
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects taking drugs known to affect glucose metabolism (other than metformin) will be excluded.
Beschrijving

Pharmaceutical Preparations Affecting Glucose metabolism | Exception Metformin

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0596620
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
individuals with evidence of proliferative diabetic retinopathy or plasma creatinine >1.4 females or >1.5 males or egfr< 60 ml/min.172m2 will be excluded
Beschrijving

Proliferative diabetic retinopathy | Plasma creatinine measurement | Gender | Estimated Glomerular Filtration Rate

Datatype

boolean

Alias
UMLS CUI [1]
C0154830
UMLS CUI [2]
C1278055
UMLS CUI [3]
C0079399
UMLS CUI [4]
C3811844
unstable body weight (change of greater than ±3 lbs over the preceding 3 months)
Beschrijving

Body Weight Unstable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005910
UMLS CUI [1,2]
C0443343
participates in excessively heavy exercise program
Beschrijving

Participation Exercise Very heavy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0015259
UMLS CUI [1,3]
C0439540
Terug naar het begin van de pagina

Similar models

Eligibility Type 2 Diabetes Mellitus NCT02324842

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male and female subjects between the ages of 18-70
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
subjects with type 2 diabetes mellitus (t2dm)
boolean
C0011860 (UMLS CUI [1])
Pharmaceutical Preparations Absent | Metformin Dose Stable
Item
drug naïve or on stable dose (more than 3 months) of metformin
boolean
C0013227 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0025598 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Hemoglobin A1c measurement
Item
have an hba1c levels ≥7.0% and <10.0%
boolean
C0474680 (UMLS CUI [1])
Stable body weight Duration
Item
stable weight (± 3 lbs) over the preceding 3 months
boolean
C0517386 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Affecting Glucose metabolism | Exception Metformin
Item
subjects taking drugs known to affect glucose metabolism (other than metformin) will be excluded.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Proliferative diabetic retinopathy | Plasma creatinine measurement | Gender | Estimated Glomerular Filtration Rate
Item
individuals with evidence of proliferative diabetic retinopathy or plasma creatinine >1.4 females or >1.5 males or egfr< 60 ml/min.172m2 will be excluded
boolean
C0154830 (UMLS CUI [1])
C1278055 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C3811844 (UMLS CUI [4])
Body Weight Unstable
Item
unstable body weight (change of greater than ±3 lbs over the preceding 3 months)
boolean
C0005910 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Participation Exercise Very heavy
Item
participates in excessively heavy exercise program
boolean
C0679823 (UMLS CUI [1,1])
C0015259 (UMLS CUI [1,2])
C0439540 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial